Topically Applied Pilocarpine
- 1 January 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 98 (1) , 112-115
- https://doi.org/10.1001/archopht.1980.01020030114010
Abstract
• Previous studies with use of animal models have shown that, for topically applied ophthalmic drugs, the fraction of dose absorbed into the eye is increased as the volume in which the drug is instilled is decreased. Such findings have not previously been confirmed in humans. In the present study, the miotic response to instilled doses of 20 and 50 μL of 0.5% pilocarpine hydrochloride was compared in ten adult human volunteers. Although the 20-μL drop represents a substantial dosage reduction, the miotic response was essentially equivalent to that obtained with the 50-μL drop. These findings imply that, due to the large drainage loss of topically applied ophthalmic drugs, volumes delivered by commercial ophthalmic droppers may in some cases be larger than required to achieve the desired response.This publication has 6 references indexed in Scilit:
- Possible Adverse Effects From Topical Ocular 10% PhenylephrineAmerican Journal of Ophthalmology, 1978
- Ocular Bioavailability and Systemic Loss of Topically Applied Ophthalmic DrugsAmerican Journal of Ophthalmology, 1978
- EYE-DROP INDUCED HYPERTENSIONThe Lancet, 1977
- Fluorinated Corticosteroid Toxicity in InfantsAmerican Journal of Ophthalmology, 1977
- Pharmacokinetic Evidence for Improved Ophthalmic Drug Delivery by Reduction of Instilled VolumeJournal of Pharmaceutical Sciences, 1977
- Comparative toxicity of two-dexamathasone derivatives following topical ocular instillation to rabbits II. Systemic histopathological changesToxicology, 1976